TACSTD2 and urinary bladder carcinoma: All bsAbs induced robust T cell activation, cytokine secretion and sustained T cell expansion, resulting in potent T cell-mediated cytotoxicity against TNBC and bladder cancer cells with either high or low levels of TROP-2 expression.